Total Payments
$502,442
2024 Payments
$4,260
Companies
11
Transactions
643
Payment Breakdown by Category
Other$383,427 (76.3%)
Travel$74,267 (14.8%)
Consulting$31,562 (6.3%)
Food & Beverage$13,149 (2.6%)
Gifts$20.00 (0.0%)
Education$17.16 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $366,177 | 173 | 72.9% |
| Travel and Lodging | $74,267 | 264 | 14.8% |
| Consulting Fee | $31,562 | 12 | 6.3% |
| Honoraria | $17,250 | 11 | 3.4% |
| Food and Beverage | $13,149 | 181 | 2.6% |
| Gift | $20.00 | 1 | 0.0% |
| Education | $17.16 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $213,737 | 255 | $0 (2021) |
| ITI, Inc. | $84,091 | 96 | $0 (2023) |
| Shire North American Group Inc | $58,062 | 85 | $0 (2019) |
| Ironshore Pharmaceuticals Inc. | $48,914 | 67 | $0 (2023) |
| Neos Therapeutics, LP | $30,118 | 41 | $0 (2019) |
| Tris Pharma Inc | $19,054 | 31 | $0 (2019) |
| Corium, LLC | $17,528 | 23 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $12,240 | 19 | $0 (2022) |
| Adlon Therapeutics L.P. | $9,542 | 9 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $8,095 | 13 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,260 | 2 | Corium, LLC ($4,260) |
| 2023 | $43,262 | 59 | ITI, Inc. ($25,889) |
| 2022 | $49,133 | 61 | ITI, Inc. ($49,111) |
| 2021 | $26,108 | 29 | Supernus Pharmaceuticals, Inc. ($9,324) |
| 2020 | $19,955 | 18 | Ironshore Pharmaceuticals Inc. ($7,200) |
| 2019 | $142,952 | 186 | Sunovion Pharmaceuticals Inc. ($87,034) |
| 2018 | $123,343 | 166 | Sunovion Pharmaceuticals Inc. ($87,218) |
| 2017 | $93,428 | 122 | Sunovion Pharmaceuticals Inc. ($29,235) |
All Payment Transactions
643 individual payment records from CMS Open Payments — Page 6 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $2.93 | General |
| Category: PSYCHOLOGY | ||||||
| 10/25/2021 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| 10/07/2021 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 10/06/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $2.81 | General |
| Category: PSYCHOLOGY | ||||||
| 09/15/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $3.21 | General |
| Category: PSYCHOLOGY | ||||||
| 09/07/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $2.13 | General |
| Category: PSYCHOLOGY | ||||||
| 08/02/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: PSYCHOLOGY | ||||||
| 08/02/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: PSYCHOLOGY | ||||||
| 08/02/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: PSYCHOLOGY | ||||||
| 08/02/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | In-kind items and services | $116.92 | General |
| Category: PSYCHOLOGY | ||||||
| 08/02/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: PSYCHOLOGY | ||||||
| 08/02/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: PSYCHOLOGY | ||||||
| 06/15/2021 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 06/10/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| Category: CNS | ||||||
| 06/09/2021 | ITI, Inc. | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2021 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| 04/27/2021 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| 03/23/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $763.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $763.00 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| Category: CNS | ||||||
| 03/20/2021 | Supernus Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| 03/18/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $763.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2021 | ITI, Inc. | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/10/2021 | ITI, Inc. | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/08/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,230.00 | General |
| Category: CNS | ||||||
About Dr. Mark Owens, DO
Dr. Mark Owens, DO is a Psychiatry healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1922218015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Owens, DO has received a total of $502,442 in payments from pharmaceutical and medical device companies, with $4,260 received in 2024. These payments were reported across 643 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($366,177).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Brooklyn, NY
- Active Since 05/23/2007
- Last Updated 04/25/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922218015
Products in Payments
- LATUDA (Drug) $213,427
- CAPLYTA (Drug) $84,091
- MYDAYIS (Drug) $51,597
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $34,409
- Adzenys XR-ODT (Drug) $30,099
- Dyanavel XR (Drug) $19,017
- JORNAY PM (Drug) $14,506
- Azstarys (Drug) $13,268
- ADHANSIA XR (Drug) $9,542
- VYVANSE (Drug) $8,254
- Vyvanse (Drug) $5,806
- QELBREE (Drug) $5,197
- AZSTARYS (Drug) $4,260
- APTIOM (Drug) $309.49
- Quillivant XR (Drug) $37.40
- Cotempla XR-ODT (Drug) $18.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Brooklyn
Dr. Nancy Abdel-Wahab, M.d, M.D
Psychiatry — Payments: $194,999
Psychiatry $194,999
Louis Belzie, Md, Phd, MD, PHD
Psychiatry — Payments: $178,082
Psychiatry $178,082
Alexander Pinkusovich, Md, MD
Psychiatry — Payments: $111,246
Psychiatry $111,246
Dr. Mark Gurtovy, M.d, M.D
Psychiatry — Payments: $31,729
Psychiatry $31,729
Thresiamma Nidhiry, Md, MD
Psychiatry — Payments: $27,833
Psychiatry $27,833
Dr. Irina Kiblitsky, M.d, M.D
Psychiatry — Payments: $22,079
Psychiatry $22,079